Salivary Heme Oxygenase-1: A Potential Biomarker for Central Neurodegeneration
Open Access
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in Journal of Central Nervous System Disease
- Vol. 13
Abstract
Background: Parkinson disease (PD) is the second most common neurodegenerative disease, affecting 2% of the population over 65 years of age. PD diagnosis is based on clinical examination and can only be confirmed during autopsy. In 2018, we reported that heme oxygenase-1 (HO-1), an inducible stress response protein important for heme catabolism and implicated in PD pathology, was higher in PD saliva relative to healthy controls, suggesting that salivary HO-1 may serve as a potential biomarker of PD. Objectives: To ascertain whether HO-1 protein levels are elevated in PD saliva relative to degenerative neurological, non-degenerative neurological and healthy controls. Methodology: The study included 307 participants comprising 75 participants with idiopathic PD and 3 control groups: 162 non-neurological, 37 non-PD degenerative neurological, and 33 non-degenerative neurological participants. Salivary HO-1 and total protein concentrations were measured using ELISA and BCA assay, respectively. Receiver operating characteristic (ROC) curves were used to estimate model discrimination. Analyses were adjusted by age, sex, total protein, and relevant comorbidities. Results: Elevated HO-1 concentrations were observed in the PD group and other neurodegenerative conditions compared to subjects with no neurological or non-degenerative neurological conditions. ROC curves using HO-1 levels and covariates yielded areas under the curve above 85% in models for PD or neurodegenerative conditions versus controls. Conclusions: Salivary HO-1 concentrations in combination with covariates may provide a biomarker signature that distinguishes patients with neurodegenerative conditions from persons without. Classification of evidence: This study provides Class III evidence that salivary HO-1 multivariable models can distinguish neurodegenerative conditions.Keywords
Funding Information
- Mitacs
- Parkinson Canada
This publication has 58 references indexed in Scilit:
- Performance of Multiplex Cytokine Assays in Serum and Saliva among Community-Dwelling Postmenopausal WomenPLOS ONE, 2013
- New technologies for studying the complexity of oral diseasesOral Diseases, 2011
- Matrix Effects—A Challenge toward Automation of Molecular AnalysisSLAS Technology, 2010
- Characterization of α1-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasmaNeurobiology of Disease, 2006
- Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairmentNeurobiology of Aging, 2006
- Salivary production in Parkinson's diseaseMovement Disorders, 2004
- Age‐related changes in immunoglobulin isotypes in whole and parotid saliva and serum in healthy individualsOral Microbiology and Immunology, 1995
- Complex I, Iron, and ferritin in Parkinson's disease substantia nigraAnnals of Neurology, 1994
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Regression modelling strategies for improved prognostic predictionStatistics in Medicine, 1984